DOCSLIB.ORG

Company Amount Exactech, Inc. 394,335.75 $ Sanofi and Genzyme

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Company Amount Exactech, Inc. 394,335.75 $ Sanofi and Genzyme Company Amount Exactech, Inc. $ 394,335.75 Sanofi and Genzyme US Companies $ 244,952.74 Allergan Inc. $ 159,254.41 Globus Medical, Inc. $ 151,112.29 Mallinckrodt LLC $ 149,348.47 St. Jude Medical, Inc. $ 117,946.44 Valeant Pharmaceuticals International $ 102,054.82 Entellus Medical, Inc. $ 83,734.64 NUVASIVE, INC. $ 74,492.73 Novartis Pharmaceuticals Corporation $ 66,982.52 Haemonetics Corporation $ 64,259.77 Abbott Laboratories $ 64,246.33 Edwards Lifesciences Corporation $ 56,674.29 Volcano Corporation $ 51,400.49 Gilead Sciences Inc $ 43,742.37 AstraZeneca Pharmaceuticals LP $ 43,659.04 AbbVie, Inc. $ 42,096.25 Boehringer Ingelheim Pharmaceuticals, Inc. $ 40,202.56 Nobel Biocare USA $ 37,546.46 Merck Sharp & Dohme Corporation $ 36,966.30 Teva Pharmaceuticals USA, Inc. $ 34,769.14 Luminex Corporation $ 32,495.65 Smith & Nephew, Inc. $ 31,152.54 Pfizer Inc. $ 30,502.05 Applied Medical Corporation $ 27,353.79 Eli Lilly and Company $ 27,316.67 Amgen Inc. $ 27,303.11 Regeneron Pharmaceuticals, Inc. $ 26,806.98 Impax Laboratories, Inc. $ 25,813.52 Bristol-Myers Squibb Company $ 25,315.70 Theravance Biopharma Inc. $ 24,214.06 Arthrex, Inc. $ 24,095.39 Spinal Elements, Inc. $ 22,963.17 Medtronic Vascular, Inc. $ 21,027.12 Biosense Webster, Inc. $ 20,566.98 Intuitive Surgical, Inc. $ 19,753.18 Ferring Pharmaceuticals Inc. $ 19,244.12 BOSTON SCIENTIFIC CORPORATION $ 16,921.68 DePuy Synthes Sales Inc. $ 15,238.02 Sunovion Pharmaceuticals Inc. $ 12,469.74 Janssen Pharmaceuticals, Inc $ 12,445.49 Stryker Corporation $ 12,161.12 Planmeca USA, Inc. $ 12,154.73 Synthes GmbH $ 11,786.51 Insulet Corporation $ 11,720.36 Lundbeck LLC $ 11,091.21 ViiV Healthcare Company $ 10,884.44 Kuraray America Inc $ 10,337.20 Cook Medical LLC $ 8,961.33 Eisai Inc. $ 8,409.28 Avanir Pharmaceuticals, Inc. $ 7,800.00 NOVADAQ TECHNOLOGIES INC. $ 7,541.02 Bayer HealthCare Pharmaceuticals Inc. $ 7,467.45 Coloplast Corp $ 7,417.65 VERTEX PHARMACEUTICALS INCORPORATED $ 7,319.47 Hiossen, Inc. $ 7,300.00 KCI USA, Inc $ 6,988.49 Cardinal Health, Inc. $ 6,978.06 Merz North America, Inc. $ 6,900.84 Ethicon Inc. $ 6,655.23 ACADIA Pharmaceuticals Inc $ 6,459.27 Medtronic USA, Inc. $ 6,388.16 Astellas Pharma Global Development $ 6,079.49 AtriCure, Inc. $ 5,837.40 Supernus Pharmaceuticals, Inc. $ 5,504.42 Cepheid $ 5,500.00 LIFECELL CORPORATION $ 5,484.66 AxoGen $ 5,395.37 Incyte Corporation $ 5,182.11 Advanced Bionics, LLC $ 5,118.93 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $ 5,000.00 Astellas Pharma US Inc $ 4,925.56 CryoLife, Inc. $ 4,883.55 Henry Schein, Inc. $ 4,855.52 Siemens Medical Solutions USA, Inc. $ 4,717.33 Zimmer Biomet Holdings, Inc. $ 4,689.73 AMAG Pharmaceuticals, Inc. $ 4,500.00 Ironwood Pharmaceuticals, Inc $ 4,260.06 W. L. Gore & Associates, Inc. $ 4,245.42 Merrimack Pharmaceuticals, Inc. $ 3,993.44 CONMED Corporation $ 3,989.52 Arrow International, Inc. $ 3,969.82 Olympus America Inc. $ 3,915.00 Celgene Corporation $ 3,780.68 3M Company $ 3,622.68 Musculoskeletal Transplant Foundation Inc. $ 3,577.11 BIOTRONIK INC. $ 3,152.85 AngioDynamics, Inc. $ 3,149.38 Sirtex Medical Inc $ 3,080.72 Alcon Laboratories Inc $ 3,044.29 Neoventa Medical, Inc. $ 3,000.00 Sirona Dental Systems Inc. $ 2,985.00 Endologix, Inc. $ 2,869.22 Mazor Robotics Inc. $ 2,856.34 GAC International LLC $ 2,725.46 C. R. Bard, Inc. & Subsidiaries $ 2,701.72 Genentech, Inc. $ 2,629.06 PATTERSON COMPANIES, INC. $ 2,500.00 NEUROPACE, INC. $ 2,300.00 Acclarent, Inc $ 2,255.14 Mentor Worldwide LLC $ 2,192.00 Covidien LP $ 2,173.50 Tulsa Dental Products LLC $ 2,153.27 ABIOMED $ 2,138.51 Illumina, Inc. $ 2,077.09 Olympus Corporation of the Americas $ 2,015.88 Cerus Corporation $ 1,922.02 Shire North American Group Inc $ 1,788.93 Acumed LLC $ 1,600.32 Carestream Dental, LLC $ 1,572.68 BTG International, Inc. $ 1,511.10 Wright Medical Technology, Inc. $ 1,430.36 Mylan Inc. $ 1,289.60 Medtronic MiniMed, Inc. $ 1,261.76 Tandem Diabetes Care, Inc. $ 1,200.00 Stereotaxis Inc $ 1,150.20 GE HEALTHCARE $ 1,085.83 Pacira Pharmaceuticals Incorporated $ 1,069.23 Cochlear Ltd $ 1,048.50 Integra LifeSciences Corporation $ 993.54 Veran Medical Technologies, Inc. $ 979.07 Convatec Inc. $ 976.41 Team 1 Orthopaedics Inc $ 966.90 Otsuka America Pharmaceutical, Inc. $ 874.08 ARIAD Pharmaceuticals, Inc. $ 839.83 Galderma Laboratories, L.P. $ 824.31 Roche Diagnostics Corporation $ 762.56 Helsinn Therapeutics (U.S.), Inc. $ 750.00 ConforMIS, Inc. $ 684.03 Hu-Friedy Mfg. Co., LLC $ 672.35 MAQUET Cardiovascular U.S. Sales, L.L.C. $ 655.64 Philips Electronics North America Corporation $ 619.20 KARLSTORZ Endoscopy-America $ 619.17 GUERBET LLC $ 606.32 Depomed, Inc. $ 601.00 Trireme Medical LLC $ 598.00 QIAGEN SCIENCES LLC $ 592.00 Hollister Incorporated $ 558.31 Masimo Corporation $ 517.28 Orthopediatrics Corp $ 509.70 KLS Martin LP $ 505.03 Animas Corporation $ 500.00 Shionogi Inc $ 499.20 Apollo Endosurgery US Inc $ 489.32 Endo Pharmaceuticals Inc. $ 481.28 Alexion Pharmaceuticals, Inc. $ 479.70 Baxalta US Inc $ 431.83 Specialty Surgical Instrumentation $ 429.78 UCB, Inc. $ 421.87 Daiichi Sankyo Inc. $ 421.62 Actelion Pharmaceuticals US, Inc. $ 413.16 Salvin Dental Specialties, Inc. $ 402.53 Organogenesis Inc. $ 398.00 ACELL, INC. $ 381.96 Premier Dental Products Company $ 375.00 Nevro Corp $ 370.75 BioDelivery Sciences International, Inc. $ 363.25 Alphatec Spine, Inc $ 337.61 DJO, LLC $ 288.43 Ivoclar Vivadent, Inc. $ 263.84 Align Technology, Inc. $ 256.25 Pharmacyclics LLC, An AbbVie Company $ 249.60 LEO Pharma Inc. $ 245.96 Intersect ENT, Inc. $ 242.67 Orexo US, Inc. $ 223.36 McKesson Specialty Care Distribution Corp. $ 221.03 US WorldMeds, LLC $ 212.25 The Spectranetics Corporation $ 210.94 Septodont Inc. $ 175.00 Straumann USA LLC $ 175.00 HILL-ROM COMPANY, INC $ 164.26 TESARO, Inc. $ 161.56 Midmark Corporation $ 149.00 Medline Industries, Inc. $ 133.32 Oticon Medical, LLC $ 131.10 Meda Pharmaceuticals, Inc. $ 125.00 United Therapeutics Corporation $ 125.00 EMD Serono, Inc. $ 123.80 BAXTER HEALTHCARE $ 122.33 Ortho Organizers, Inc. $ 120.43 Jazz Pharmaceuticals Inc. $ 120.32 Taiho Oncology, Inc. $ 118.40 Medivation Inc. $ 113.89 Takeda Pharmaceuticals U.S.A., Inc. $ 113.63 ADVANCED RESPIRATORY, INC $ 112.04 Covidien Sales LLC $ 111.76 Grace Medical, Inc. $ 111.38 Cogentix Medical Inc. $ 111.23 American Orthodontics Corporation $ 111.02 Seattle Genetics, Inc. $ 110.19 Dentsply International $ 110.18 Vitrolife Inc. $ 109.79 SI-BONE, Inc. $ 108.33 Vascular Solutions, Inc. $ 106.50 Alkermes, Inc. $ 106.07 Chiesi USA, Inc. $ 105.98 Promius Pharma LLC $ 105.50 Sanofi Pasteur Inc. $ 104.66 Cardiovascular Systems Inc. $ 104.40 Vioptix Inc $ 100.36 Vapotherm Inc $ 100.23.
Load more

Recommended publications
  • March 31, 2021
    Units Cost Market Value US Equity Index Fund US Equities 95.82% Domestic Common Stocks 10X GENOMICS INC 126 10,868 24,673 1LIFE HEALTHCARE INC 145 6,151 4,794 2U INC 101 5,298 4,209 3D SYSTEMS CORP 230 5,461 9,193 3M CO 1,076 182,991 213,726 8X8 INC 156 2,204 4,331 A O SMITH CORP 401 17,703 28,896 A10 NETWORKS INC 58 350 653 AAON INC 82 3,107 5,132 AARON'S CO INC/THE 43 636 1,376 ABBOTT LABORATORIES 3,285 156,764 380,830 ABBVIE INC 3,463 250,453 390,072 ABERCROMBIE & FITCH CO 88 2,520 4,086 ABIOMED INC 81 6,829 25,281 ABM INDUSTRIES INC 90 2,579 3,992 ACACIA RESEARCH CORP 105 1,779 710 ACADIA HEALTHCARE CO INC 158 8,583 9,915 ACADIA PHARMACEUTICALS INC 194 6,132 4,732 ACADIA REALTY TRUST 47 1,418 1,032 ACCELERATE DIAGNOSTICS INC 80 1,788 645 ACCELERON PHARMA INC 70 2,571 8,784 ACCO BRANDS CORP 187 1,685 1,614 ACCURAY INC 64 483 289 ACI WORLDWIDE INC 166 3,338 6,165 ACTIVISION BLIZZARD INC 1,394 52,457 133,043 ACUITY BRANDS INC 77 13,124 14,401 ACUSHNET HOLDINGS CORP 130 2,487 6,422 ADAPTHEALTH CORP 394 14,628 10,800 ADAPTIVE BIOTECHNOLOGIES CORP 245 11,342 10,011 ADOBE INC 891 82,407 521,805 ADT INC 117 716 1,262 ADTALEM GLOBAL EDUCATION INC 99 4,475 3,528 ADTRAN INC 102 2,202 2,106 ADVANCE AUTO PARTS INC 36 6,442 7,385 ADVANCED DRAINAGE SYSTEMS INC 116 3,153 13,522 ADVANCED ENERGY INDUSTRIES INC 64 1,704 7,213 ADVANCED MICRO DEVICES INC 2,228 43,435 209,276 ADVERUM BIOTECHNOLOGIES INC 439 8,321 1,537 AECOM 283 12,113 17,920 AERIE PHARMACEUTICALS INC 78 2,709 1,249 AERSALE CORP 2,551 30,599 31,785 AES CORP/THE 1,294 17,534 33,735 AFFILIATED
    [Show full text]
  • 2019 National Capacity Assessment Report
    National Capacity Assessment Report Pursuant to CERCLA Section 104(c)(9) December 17, 2019 U.S. Environmental Protection Agency [Page intentionally left blank.] Acronyms Used in this Report BIFs Boilers and Industrial Furnaces BR Biennial Report or Hazardous Waste Report BTU British Thermal Unit CA Cooperative Agreement CAP Capacity Assurance Plan CERCLA Comprehensive Environmental Response, Compensation, and Liability Act CFR Code of Federal Regulations EPA U.S. Environmental Protection Agency EPA ID EPA Identification Number FR Federal Register GM Form Waste Generation and Management Form LQG Large Quantity Generator RCRA Resource Conservation and Recovery Act, as amended SARA 1986 Superfund Amendments and Reauthorization Act SQG Small Quantity Generator SSC State Superfund Contract TSDFs Treatment, Storage, and Disposal Facilities VSQG Very Small Quantity Generator WR Form Waste Received from Offsite Form [Page intentionally left blank.] Table of Contents Executive Summary .................................................................................................................. i 1. Introduction ................................................................................................................. 1 Background..................................................................................................................................... 1 Purpose and Organization of Report .............................................................................................. 3 2. Data Development ......................................................................................................
    [Show full text]
  • LIST of DISCLOSURES Last Name First Name Role Session Type
    LIST OF DISCLOSURES B. Research Grant (e.g. principal investigator, collaborator C. Other Research Support (e.g. receipt of drugs, supplies, D. Speakers Bureau/Honoraria (e.g. speakers bureau, E. Ownership Interest (e.g. stock options, patent or other Last Name First Name Role Session Type Session Title Day Start Time End Time A. Employment (full or part-time) or consultant and pending grants as well as grants already F. Consultant/Advisory Board (including volunteer roles) equipment or other in-kind support) symposia, and expert witness) intellectual property) received) Amit Mahajan Speaker Sessions in Co-operation Lung Surgery of the Future in co-operation with International Society for Minimally Monday 10 June 2019 16:00 17:00 Auris Robotics with other Societies Invasive Cardiothoracic Surgery (ISMICS) Arnaud Scherpereel Chair Sessions in Co-operation Mesothelioma Guidelines in co-operation with ERS/ESTRO/EACTS Tuesday 11 June 2019 15:00 16:00 BMS, Roche, Astra-Zeneca, MSD BMS, Roche, Astra-Zeneca, MSD with other Societies Arnaud Scherpereel Speaker Sessions in Co-operation Mesothelioma Guidelines in co-operation with ERS/ESTRO/EACTS Tuesday 11 June 2019 15:00 16:00 BMS, Astra-Zeneca, Roche, MSD BMS, Astra-Zeneca, Roche, MSD with other Societies Brendon Stiles Chair Educational Session ESTS Biology Club Sunday 9 June 2019 15:30 17:30 Pfizer, PPD AstraZeneca, Merck, Covidien, Lung Cancer Research Foundation Brendon Stiles Speaker Sessions in Co-operation ESTS-STS (Society of Thoracic Surgeons) Joint Session Tuesday 11 June 2019 15:00
    [Show full text]
  • Kevin M. Flannery
    Kevin M. Flannery Partner Philadelphia | Cira Centre, 2929 Arch Street, Philadelphia, PA, United States of America 19104- 2808 T +1 215 994 2814 | F +1 215 994 2222 [email protected] Services Intellectual Property > Patent Litigation > Hatch-Waxman Litigation > IP Litigation > Litigation > Trade Secrets and Unfair Competition > IP and Technology Licensing and Transactions > Life Sciences > Telecommunications, Media and Technology > Kevin M. Flannery is a nationally recognized trial lawyer who represents clients in complex patent and trade secret cases across a wide spectrum of technology areas. He has extensive experience acting as lead trial counsel in patent cases involving medical devices, pharmaceuticals, electronics, software and consumer products. Most recently, Mr. Flannery was co-counsel in a case before the U.S. Supreme Court on behalf of SCA Hygiene Products, where in a 7-1 decision, the Supreme Court overturned 100 years of precedent, concluding that laches cannot bar the award of legal damages in patent cases. Other successes include winning a US$22 million jury award in a patent case (settled favorably prior to appeal), a favorable pre-verdict settlement after a two-week jury trial in a trade secret case, and a US$4.6 million jury verdict in a patent infringement case, which was affirmed on appeal. Mr. Flannery also represents branded clients in litigation under the Hatch-Waxman Act. On behalf of Endo Pharmaceuticals, he was part of the trial team that prevailed in a five-week bench patent trial against seven manufacturers of generic drugs, winning injunctions against all seven and protecting Endo’s sales of its OPANA® ER tablets, which at its peak was the company’s second highest-selling product with US$300 million in annual sales.
    [Show full text]
  • L'institution Royale Pour L'avancement
    L’INSTITUTION ROYALE POUR L’AVANCEMENT DES SCIENCES / UNIVERSITÉ McGILL ACTIONS AMÉRICAINES │ au 31 mars 2019 Actions américaines d’une valeur supérieure à 500 000 $ cotées en bourse et détenues dans des comptes distincts (en $ CAN) GRAND CANYON EDUCATION INC 2 464 502 WADDELL & REED FINANCIAL INC 838 294 VIRTU FINANCIAL INC 2 098 163 DXP ENTERPRISES INC/TX 829 531 EURONET WORLDWIDE INC 2 075 232 OSHKOSH CORP 772 848 IRIDIUM COMMUNICATIONS INC 2 021 967 CIENA CORP 748 266 MARKETAXESS HOLDINGS INC 1 969 545 SNAP‐ON INC 710 950 UNIVERSAL HEALTH SERVICES INC 1 924 707 PULTEGROUP INC 705 975 MAXIMUS INC 1 697 760 VISHAY INTERTECHNOLOGY INC 703 237 ENVESTNET INC 1 539 593 UNUM GROUP 659 850 CHARLES RIVER LABORATORIES INT 1 531 805 LEAR CORP 652 686 CHEMED CORP 1 484 619 JETBLUE AIRWAYS CORP 649 127 MARRIOTT VACATIONS WORLDWIDE C 1 442 976 AVNET INC 643 136 US SILICA HOLDINGS INC 1 434 222 AMC NETWORKS INC 636 960 ACUSHNET HOLDINGS CORP 1 352 421 HUNTINGTON INGALLS INDUSTRIES 636 660 GENTHERM INC 1 321 685 WESTROCK CO 635 298 LAUREATE EDUCATION INC 1 308 706 CIT GROUP INC 628 038 FOX FACTORY HOLDING CORP 1 274 121 DOMTAR CORP 623 501 HURON CONSULTING GROUP INC 1 242 872 REGIONS FINANCIAL CORP 614 370 INTL. FCSTONE INC 1 242 806 ARBOR REALTY TRUST INC 608 950 RE/MAX HOLDINGS INC 1 238 584 QUEST DIAGNOSTICS INC 600 643 TEMPUR SEALY INTERNATIONAL INC 1 225 928 OWENS CORNING 598 025 GLOBUS MEDICAL INC 1 212 789 GLOBAL BRASS & COPPER HOLDINGS 593 531 THERMON GROUP HOLDINGS INC 1 209 830 FEDERAL AGRICULTURAL MORTGAGE 590 253 SHUTTERSTOCK INC 1 202
    [Show full text]
  • BNYM Investment Port:Midcap Stock Port (Unaudited) As of Date: 09/30/2020 Common Stocks
    BNYM Investment Port:MidCap Stock Port (Unaudited) As of date: 09/30/2020 Common Stocks Identifier Security Description Shares Market Value ($) 002535300 Aaron's 7,450 422,043 00404A109 Acadia Healthcare 5,480 161,550 004498101 ACI Worldwide 13,250 346,223 00508Y102 Acuity Brands 9,470 969,255 BD845X2 Adient 12,480 216,278 00737L103 Adtalem Global Education 6,800 166,872 00766T100 AECOM 4,170 174,473 018581108 Alliance Data Systems 7,130 299,317 01973R101 Allison Transmission Holdings 7,110 249,845 00164V103 AMC Networks 10,710 264,644 023436108 Amedisys 2,760 652,547 025932104 American Financial Group 3,310 221,704 03073E105 AmerisourceBergen 2,220 215,162 042735100 Arrow Electronics 5,620 442,069 04280A100 Arrowhead Pharmaceuticals 5,670 244,150 045487105 Associated Banc-Corp 47,940 605,003 05329W102 Autonation 6,980 369,451 05368V106 Avient 23,030 609,374 053774105 Avis Budget Group 10,600 278,992 05464C101 Axon Enterprise 2,410 218,587 062540109 Bank of Hawaii 4,830 244,012 06417N103 Bank OZK 6,630 141,352 090572207 Bio-Rad Laboratories 1,480 762,881 09073M104 Bio-Techne 880 218,002 05550J101 BJs Wholesale Club Holdings 11,270 468,269 09227Q100 Blackbaud 3,750 209,363 103304101 Boyd Gaming 18,350 563,162 105368203 Brandywine Realty Trust 93,500 966,790 11120U105 Brixmor Property Group 6,300 73,647 117043109 Brunswick 8,150 480,117 12685J105 Cable One 300 565,629 127190304 CACI International, Cl. A 3,980 848,377 12769G100 Caesars Entertainment 11,890 666,553 133131102 Camden Property Trust 11,390 1,013,482 134429109 Campbell Soup 4,440
    [Show full text]
  • Annual Report
    ANNUAL REPORT 2019 MARCH 2020 To Our Shareholders Alex Gorsky Chairman and Chief Executive Officer By just about every measure, Johnson & These are some of the many financial and Johnson’s 133rd year was extraordinary. strategic achievements that were made possible by the commitment of our more than • We delivered strong operational revenue and 132,000 Johnson & Johnson colleagues, who adjusted operational earnings growth* that passionately lead the way in improving the health exceeded the financial performance goals we and well-being of people around the world. set for the Company at the start of 2019. • We again made record investments in research and development (R&D)—more than $11 billion across our Pharmaceutical, Medical Devices Propelled by our people, products, and and Consumer businesses—as we maintained a purpose, we look forward to the future relentless pursuit of innovation to develop vital with great confidence and optimism scientific breakthroughs. as we remain committed to leading • We proudly launched new transformational across the spectrum of healthcare. medicines for untreated and treatment-resistant diseases, while gaining approvals for new uses of many of our medicines already in the market. Through proactive leadership across our enterprise, we navigated a constant surge • We deployed approximately $7 billion, of unique and complex challenges, spanning primarily in transactions that fortify our dynamic global issues, shifting political commitment to digital surgery for a more climates, industry and competitive headwinds, personalized and elevated standard of and an ongoing litigious environment. healthcare, and that enhance our position in consumer skin health. As we have experienced for 133 years, we • And our teams around the world continued can be sure that 2020 will present a new set of working to address pressing public health opportunities and challenges.
    [Show full text]
  • Usef-I Q2 2021
    Units Cost Market Value U.S. EQUITY FUND-I U.S. Equities 88.35% Domestic Common Stocks 10X GENOMICS INC 5,585 868,056 1,093,655 1ST SOURCE CORP 249 9,322 11,569 2U INC 301 10,632 12,543 3D SYSTEMS CORP 128 1,079 5,116 3M CO 11,516 2,040,779 2,287,423 A O SMITH CORP 6,897 407,294 496,998 AARON'S CO INC/THE 472 8,022 15,099 ABBOTT LABORATORIES 24,799 2,007,619 2,874,948 ABBVIE INC 17,604 1,588,697 1,982,915 ABERCROMBIE & FITCH CO 1,021 19,690 47,405 ABIOMED INC 9,158 2,800,138 2,858,303 ABM INDUSTRIES INC 1,126 40,076 49,938 ACACIA RESEARCH CORP 1,223 7,498 8,267 ACADEMY SPORTS & OUTDOORS INC 1,036 35,982 42,725 ACADIA HEALTHCARE CO INC 2,181 67,154 136,858 ACADIA REALTY TRUST 1,390 24,572 30,524 ACCO BRANDS CORP 1,709 11,329 14,749 ACI WORLDWIDE INC 6,138 169,838 227,965 ACTIVISION BLIZZARD INC 13,175 839,968 1,257,422 ACUITY BRANDS INC 1,404 132,535 262,590 ACUSHNET HOLDINGS CORP 466 15,677 23,020 ADAPTHEALTH CORP 1,320 39,475 36,181 ADAPTIVE BIOTECHNOLOGIES CORP 18,687 644,897 763,551 ADDUS HOMECARE CORP 148 13,034 12,912 ADOBE INC 5,047 1,447,216 2,955,725 ADT INC 3,049 22,268 32,899 ADTALEM GLOBAL EDUCATION INC 846 31,161 30,151 ADTRAN INC 892 10,257 18,420 ADVANCE AUTO PARTS INC 216 34,544 44,310 ADVANCED DRAINAGE SYSTEMS INC 12,295 298,154 1,433,228 ADVANCED MICRO DEVICES INC 14,280 895,664 1,341,320 ADVANSIX INC 674 15,459 20,126 ADVANTAGE SOLUTIONS INC 1,279 14,497 13,800 ADVERUM BIOTECHNOLOGIES INC 1,840 7,030 6,440 AECOM 5,145 227,453 325,781 AEGLEA BIOTHERAPEUTICS INC 287 1,770 1,998 AEMETIS INC 498 6,023 5,563 AERSALE CORP
    [Show full text]
  • Wilmington Funds Holdings Template DRAFT
    Wilmington Large-Cap Strategy Fund as of 5/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS APPLE INC 4.97% MICROSOFT CORP 4.69% AMAZON.COM INC 3.45% FACEBOOK INC 1.99% ALPHABET INC 1.80% ALPHABET INC 1.77% BERKSHIRE HATHAWAY INC 1.48% JPMORGAN CHASE & CO 1.35% TESLA INC 1.20% JOHNSON & JOHNSON 1.12% UNITEDHEALTH GROUP INC 0.98% VISA INC 0.96% NVIDIA CORP 0.96% BANK OF AMERICA CORP 0.89% HOME DEPOT INC/THE 0.87% WALT DISNEY CO/THE 0.82% MASTERCARD INC 0.80% PAYPAL HOLDINGS INC 0.77% EXXON MOBIL CORP 0.68% PROCTER & GAMBLE CO/THE 0.67% COMCAST CORP 0.66% ADOBE INC 0.62% INTEL CORP 0.59% VERIZON COMMUNICATIONS INC 0.59% CISCO SYSTEMS INC 0.57% CHEVRON CORP 0.55% PFIZER INC 0.54% NETFLIX INC 0.54% AT&T INC 0.53% SALESFORCE.COM INC 0.53% ABBOTT LABORATORIES 0.51% ABBVIE INC 0.50% MERCK & CO INC 0.48% WELLS FARGO & CO 0.48% BROADCOM INC 0.47% THERMO FISHER SCIENTIFIC INC 0.47% ACCENTURE PLC 0.46% CITIGROUP INC 0.45% MCDONALD'S CORP 0.44% TEXAS INSTRUMENTS INC 0.44% COCA-COLA CO/THE 0.44% HONEYWELL INTERNATIONAL INC 0.44% LINDE PLC 0.43% MEDTRONIC PLC 0.43% NIKE INC 0.43% ELI LILLY & CO 0.42% PEPSICO INC 0.42% UNITED PARCEL SERVICE INC 0.41% WALMART INC 0.40% DANAHER CORP 0.40% UNION PACIFIC CORP 0.40% QUALCOMM INC 0.38% BRISTOL-MYERS SQUIBB CO 0.37% ORACLE CORP 0.37% LOWE'S COS INC 0.36% BLACKROCK INC 0.35% CATERPILLAR INC 0.35% AMGEN INC 0.35% BOEING CO/THE 0.35% MORGAN STANLEY 0.35% COSTCO WHOLESALE CORP 0.35% RAYTHEON TECHNOLOGIES CORP 0.34% STARBUCKS CORP 0.34% GOLDMAN SACHS GROUP INC/THE 0.34% GENERAL ELECTRIC
    [Show full text]
  • UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT of FLORIDA Miami Division in Re: MIAMI INTERNATIONAL MEDI
    Case 18-12741-LMI Doc 97 Filed 04/03/18 Page 1 of 23 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF FLORIDA Miami Division www.flsb.uscourts.gov In re: MIAMI INTERNATIONAL MEDICAL CENTER, LLC1 Case No. 18-12741-LMI d/b/a THE MIAMI MEDICAL CENTER, Chapter 11 Debtor. / SUPPLEMENTAL CERTIFICATE OF SERVICE I HEREBY CERTIFY that a true and correct copy of the Debtor’s Motion for Entry of (A) an Order Approving Bidding Procedures, (B) Approving Certain Protections to Stalking Horse Purchaser, (C) Approving Notice Procedures, and (D) an Order (I) Approving the Asset Purchase Agreement, (II) Authorizing the Sale of all or Substantially all of the Assets of the Debtor Free and Clear of all Liens, Claims, Encumbrances and Other Interests, (III) Authorizing the Assumption and Assignment of Certain Executory Contracts and Unexpired Leases, (IV) Scheduling Dates to Conduct Auction and Hearing to Consider Final Approval of Sale, and (V) Granting Related Relief [ECF No. 84] was served via Regular U.S. Mail on April 2, 2018, on all REMAINDER OF PAGE LEFT INTENTIONALLY BLANK 1The Debtor’s current mailing address is 5959 NW 7 St, Miami, FL 33126 and its EIN ends 4362. 1 LAW OFFICES OF MELAND RUSSIN & BUDWICK, P.A. 3200 SOUTHEAST FINANCIAL CENTER, 200 SOUTH BISCAYNE BOULEVARD, MIAMI, FLORIDA 33131 • TELEPHONE (305) 358-6363 Case 18-12741-LMI Doc 97 Filed 04/03/18 Page 2 of 23 parties listed on the Court’s Matrix attached hereto as Exhibit 12, and to all parties listed on the Patients Matrix which was filed under seal pursuant to Court Order [ECF No.
    [Show full text]
  • 1St Quarter 2014 FINAL BOOK
    SCOTT-MACON HEALTHCARE REVIEW: FIRST QUARTER 2014 Healthcare Overview, Mean Revenue Multiples 2 Healthcare Overview, Mean EBITDA Multiples 4 Analysis of Selected Healthcare 6 Merger and Acquisition Transactions January 1—March 31, 2014 Analysis of Selected 22 CONTENTS Publicly-Traded Healthcare Companies SCOTT-MACON Healthcare Investment Banking 2 FIRST QUARTER 2014 HEALTHCARE REVIEW Dear Clients and Friends, Scott-Macon is pleased to present our quar- quisition of an Oklahoma health insurer by an invest- terly Healthcare Review covering the first quarter of ment firm, perhaps indicating that the perceived op- 2014. If you haven’t done so already, please email me portunities in this sector are now more significant at [email protected] to automatically con- than the potential pitfalls now that the Affordable tinue receiving our publications in the future as we Care Act is in full swing. Turning to Technology, are transitioning to digital publishing with email dis- once again we are seeing an incredibly diverse group tribution. of acquirors attracted to Healthcare Technology com- Pages four and five represent a visual snapshot panies—international companies, medical equipment of the average multiples for all of the healthcare, makers, private equity/investment firms and their medical and pharmaceutical transactions that either portfolio companies, and of course other Healthcare closed or were announced during the first quarter, (as well as Non-Healthcare) Technology companies, along with the average multiples for the major pub- both publicly-traded and privately-held. Outsourcing licly-traded healthcare, medical and pharmaceutical companies witnessed one of the busiest quarters we companies. have ever seen for this segment, a perennial favorite due to the inherent growth characteristics of the in- In the Insurance sector, there were two deals of dustry and the opportunities to create efficiencies for note in the First Quarter: the merger of two of the providers, payors and product companies as well.
    [Show full text]
  • Manufacturers/Wholesalers Street City ST Zip 454 Life Sciences Branford CT A.L.I Holdings, LLC A.L.I
    Manufacturers/Wholesalers Street City ST Zip 454 Life Sciences Branford CT A.L.I Holdings, LLC A.L.I. Imaging Systems Corp A.L.I. Technologies (International) LLC Abbott Diabetes Care Division Abbott Diagnostic Division Abbott Laboratories 100 Abbott Park Rd. Bldg. AP6D-1 Abbott Park IL 60064 Abbott Molecular Division Abbott Nutrition Products Division Abbott Pharmaceutical Products Group Abbott Point of Care Division Abbott Vascular Division Abraxis Bioscience, LLC. 11755 Wilshire Blvd., Suite 2000 Los Angeles CA 90025 Access Diabetic Supply, LLC Acclarent, Inc. 1525-B O'Brien Dr. Menlo Park CA 94025 Acorda Therapeutics, Inc. 15 Skyline Drive Hawthorne NY 10532 Advanced Neuromodulation Systems, Inc. Advanced Respiratory, Inc. Advanced Sterilization Products 33 Technology Drive Irvine CA 92618 Aesculap Implant Systems, Inc. 3773 Corporate Parkway Center Valley PA 18034 Aesculap, Inc. 3773 Corporate Parkway Center Valley PA 18034 Alaven Pharmaceuticals, LLC 2260 Northwest parkway Suite A Marietta GA 30067 Alcon Laboratories, Inc. 6201 South Freeway Fort Worth TX 76134 Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire CT 06410 Alkermes, Inc. 88 Sidney Street Cambridge MA 02139 Allen Medical Systems, Inc. Allergan Sales, LLC Allergan USA, Inc. Allergan, Inc. 2525 Dupont Drive Irvine CA 92612 Alpharma Pharmaceuticals, Inc. Alpharma Pharmaceuticals, LLC AMAG Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421 AMATECH Corporation American Medical Distributors, Inc. 100 New Highway N Amityville NY 11701 American Medical System,
    [Show full text]